Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Br J Nutr ; 106(3): 383-9, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21385509

RESUMO

Although resveratrol has widely been studied for its potential health benefits, little is known about its metabolic effects in humans. Our aims were to determine whether the polyphenol resveratrol improves insulin sensitivity in type 2 diabetic patients and to gain some insight into the mechanism of its action. After an initial general examination (including blood chemistry), nineteen patients enrolled in the 4-week-long double-blind study were randomly assigned into two groups: a resveratrol group receiving oral 2 × 5 mg resveratrol and a control group receiving placebo. Before and after the second and fourth weeks of the trial, insulin resistance/sensitivity, creatinine-normalised ortho-tyrosine level in urine samples (as a measure of oxidative stress), incretin levels and phosphorylated protein kinase B (pAkt):protein kinase B (Akt) ratio in platelets were assessed and statistically analysed. After the fourth week, resveratrol significantly decreased insulin resistance (homeostasis model of assessment for insulin resistance) and urinary ortho-tyrosine excretion, while it increased the pAkt:Akt ratio in platelets. On the other hand, it had no effect on parameters that relate to ß-cell function (i.e. homeostasis model of assessment of ß-cell function). The present study shows for the first time that resveratrol improves insulin sensitivity in humans, which might be due to a resveratrol-induced decrease in oxidative stress that leads to a more efficient insulin signalling via the Akt pathway.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Resistência à Insulina/fisiologia , Estresse Oxidativo/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/uso terapêutico , Proteínas Proto-Oncogênicas c-akt/sangue , Estilbenos/uso terapêutico , Adulto , Plaquetas/metabolismo , Diabetes Mellitus Tipo 2/sangue , Método Duplo-Cego , Humanos , Masculino , Pessoa de Meia-Idade , Extratos Vegetais/farmacologia , Resveratrol , Transdução de Sinais/efeitos dos fármacos , Estilbenos/farmacologia , Tirosina/urina
2.
Eur J Clin Invest ; 41(2): 195-202, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20955211

RESUMO

BACKGROUND: Epidemiological studies suggest that cigarette smoking - probably by eliciting hyperperfusion - increases glomerular filtration rate; thus, we hypothesized that cigarette smoke affects the vasomotor tone of renal arteries. MATERIALS AND METHODS: Acute changes in the resistance index of a segmental renal artery were measured in healthy individuals during smoking. In addition, the effects of water-soluble components of cigarette smoke on the isometric tension of isolated rat renal arteries were investigated in various conditions. RESULTS: In humans, cigarette smoking transiently reduced the resistance index of the renal artery segments (83·25 ± 5·67% of the baseline, P < 0·05). In the experimental model, water-soluble components of cigarette smoke (wCS) - either nicotinic or nicotine-free - elicited dose-dependent relaxations of rat isolated renal arteries (1% solution of nicotinic wCS: 41·18 ± 14·86% relaxation, 5% nicotinic wCS: 79·28 ± 8·91% relaxation, 10% nicotinic wCS 90·3 ± 6·1% relaxation, P < 0·05), which were not affected by removal of the endothelium, or by the soluble guanylate cyclase inhibitor oxadiazolo-quinoxalin-1, or the non specific potassium channel blocker tetraethylammonium, or the K(ATP) channel blocker glibenclamide. However, relaxations were reduced by catalase (1000 U mL⁻¹ catalase + 5% nicotinic wCS: 49·71 ± 18·4%, P < 0·05) and enhanced by superoxide dismutase (200 U mL⁻¹ SOD + 5% nicotinic wCS: 95·7 ± 2·3%, P < 0·05). CONCLUSIONS: On the basis of these findings, we propose that cigarette smoking could contribute to the increased glomerular filtration rate observed in healthy smokers. In addition, cigarette smoke via hydrogen peroxide mediation reduces vasomotor tone of renal arteries, which could lead to hyperperfusion of kidneys.


Assuntos
Nicotina/farmacologia , Artéria Renal/efeitos dos fármacos , Fumar , Vasodilatação/efeitos dos fármacos , Vasodilatadores/farmacologia , Adulto , Animais , Humanos , Masculino , Ratos , Estatística como Assunto , Adulto Jovem
3.
Diabetes Res Clin Pract ; 68 Suppl1: S36-42, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15955373

RESUMO

Increasing number of diabetic patients develop different stages of renal failure. However, often an inappropriate parameter, the serum creatinine is measured as a marker of glomerular function. Calculated glomerular filtration rate or endogenous creatinine clearance are suggested to be used for the estimation of the glomerular function. Important structures preventing proteinuria in the kidney are glomerular basement membrane, podocytes and proximal tubular cells. In diabetes mellitus loss of nephrin of podocytes can play a role in the development of microalbuminuria, and podocyte desquamation may result in the progression to proteinuria. In diabetes mellitus there is an increased formation of advanced glycation endproducts (AGE), of which the only elimination organ is the kidney. The AGE induce proteinuria and atherosclerosis. Therefore, in diabetes mellitus a vicious circle develops due to proteinuria, nephron loss and accumulation of AGE, which play a role in the initiation and progression of diabetic nephropathy and atherosclerosis. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers having antiproteinuric effect may decrease the risk of diabetic nephropathy and atherosclerosis. Improvement of carbohydrate metabolism with a consequential decrease in the formation of AGE is an important contributor to the prevention and treatment of diabetic nephropathy and atherosclerosis.


Assuntos
Nefropatias Diabéticas/tratamento farmacológico , Nefropatias Diabéticas/prevenção & controle , Falência Renal Crônica/prevenção & controle , Albuminúria/prevenção & controle , Creatinina/sangue , Nefropatias Diabéticas/sangue , Humanos , Rim/patologia , Rim/fisiopatologia , Falência Renal Crônica/sangue , Falência Renal Crônica/tratamento farmacológico , Proteinúria/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA